25 results for “Peripheral Neuropathy”. Showing 25 of 39,449.
Docosahexaenoic acid improved vincristine-induced peripheral neuropathy in a rat model.
Peripheral neuropathy is a common and debilitating complication of chemotherapy
tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase.
peripheral neuropathy. CMT mutant tRNA synthetases inhibit protein synthesis by an unknown
The Parkinson's disease DJ-1/PARK7 gene controls peripheral neuronal excitability and painful neuropathy.
peripheral neuropathies. Pain and mechanisms associated with these neuropathies were
Molecular characterization of recessively inherited ataxic and neuropathic disorders in consanguineous Pakistani families.
Peripheral neuropathy, which affects peripheral nervous system is manifested as sensory
Dimethyl Fumarate Ameliorates Paclitaxel-Induced Neuropathic Pain in Rats.
peripheral neuropathy (PIPN) is nonresponsive to the currently available analgesics
PCSK9 deficiency promotes the development of peripheral neuropathy.
peripheral neuropathy, characterized by reduced thermal and mechanical pain sensations
Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy.
peripheral neuropathy (CIPN) is the most common off-target adverse
Hyperglycemia promotes SIRT3-mediated deacetylation of SARM1 to exacerbate diabetic peripheral neuropathy in mice.
peripheral neuropathy (DPN), the most common complication of diabetes, lacks
Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy.
peripheral neuropathy (CIPN) is a troublesome side effect in patients
Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
peripheral neuropathy (CIPN) is a disabling pain condition which occurs
Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
peripheral neuropathies sometimes accurately recreate the pathophysiology of the human
NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy.
neuropathy, referred to as oxaliplatin-induced peripheral neuropathy (OIPN), for which
Leber Hereditary Optic Neuropathy.
peripheral neuropathy, nonspecific myopathy, and movement disorders have been reported
Glial cell alterations in diabetes-induced neurodegeneration.
peripheral neuropathy, and cognitive decline, are intimately associated with neurodegeneration
Amelioration of Chemotherapy Induced Neuropathic Pain using Novel Nicotinic Acid Derivatives with possible HCN channel binding ability.
peripheral nerve degeneration, leading to the development of painful neuropathy
Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family.
neuropathy type 1 (HSAN1/HSN1) is a peripheral neuropathy most commonly
Tang Bi formula alleviates diabetic sciatic neuropathy via AMPK/PGC-1α/MFN2 pathway activation.
peripheral neuropathy (DPN) is one of the most common chronic
Calcium-Mediated Calpain Activation and Microtubule Dissociation in Cell Model of Hereditary Sensory Neuropathy Type-1 Expressing V144D
neuropathy type 1A (HSN1A) is an autosomal, dominantly inherited peripheral
Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders.
peripheral neuropathies to cancers. Advances in selective HDAC6 inhibitor discovery
TREM2 deficiency impairs the energy metabolism of Schwann cells and exacerbates peripheral neurological deficits.
neuropathy. These results indicate that TREM2 is a critical regulator of energy metabolism in SCs and exerts neuroprotective effects on peripheral
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
neuropathy that results from loss of function mutations in the SH3TC2 gene. Sh3tc2-/- mice represent a well characterized disease model developing early onset progressive peripheral
BIN1 reduction ameliorates DNM2-related Charcot-Marie-Tooth neuropathy.
concepts for DNM2-CMT peripheral neuropathy versus DNM2-CNM myopathy.
Ataxia and oculomotor apraxia caused by a large-scale deletion in the senataxin gene.
neuropathy (AOA2, MIM #606002) and autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4, MIM #602433), rare neurodegenerative disorders characterized by juvenile onset of progressive cerebellar ataxia, axonal sensorimotor peripheral
Diverse cell types establish a pathogenic immune environment in peripheral neuropathy.
neuropathy in which SARM1, the central executioner of axon degeneration, is activated by hypomorphic mutations in the axon survival factor NMNAT2. Macrophage depletion blocked and reversed neuropathic phenotypes in this
SIRT3 alleviates painful diabetic neuropathy by mediating the FoxO3a-PINK1-Parkin signaling pathway to activate mitophagy.
peripheral neuropathy. Mitochondrial membrane potential (MMP), ATP, tissue reactive oxygen